Mazdutide Ameliorates Non-Alcoholic Fatty Liver Disease by Modulating Endoplasmic Reticulum StressLiangyu Gan(Henan University of Science and Technology), Xueyi Zheng(Henan University of Science and Technology)Preprints.orgJanuary 15, 202610.20944/preprints202601.1103.v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersMazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation|Pharmaceuticals|2026|0